2025 Critical Care Congress Skip to main content
2025 Critical Care Congress Main banner
Final Program


Back

Pharmacology
One-Hour Concurrent Session

Treatment Strategies for Opioid Use Disorder in the ICU

Monday, February 24, 2025
11:00am – 12:00pm Eastern Time
Location: W414
CE: 1

Critical care admissions for opioid overdose and complications related to opioid use disorder (OUD) have increased during the past decade. More than ever, critical care practitioners are faced with treating opioid withdrawal or polysubstance withdrawal in addition to other comorbidities leading to hospital admission. Speakers will review evidence on treatment approaches for OUD in the ICU to reduce the likelihood of patients leaving against medical advice, as well as opportunities to connect with rehabilitation programs and improve overall patient outcomes. The use of methadone and buprenorphine for general pain management in the ICU will be discussed.

Learning Objectives:

  • Compare agents for opioid use disorder (OUD) in critically ill patients based on clinical scenario, kinetic and dynamic properties, and adverse effects
  • Assess strategies for the treatment of OUD in critically ill patients, including when and how to initiate, escalate, and expand therapy
  • Evaluate the potential advantages of buprenorphine or methadone for pain management in the ICU

Presentations:

  • 11:05am – 11:20am Eastern Time
    Contextualizing the Agents and Use Cases for Opioid Use Disorder

    Jeremiah Duby, BCCCP, BCPS, PharmD – University of California Davis Medical Center

  • 11:20am – 11:35am Eastern Time
    Untangling Pain, Withdrawal, Abuse, and Addiction

    Brian Erstad, PharmD, , MCCM (he/him/his) – University of Arizona College of Pharmacy

  • 11:35am – 11:50am Eastern Time
    Amplifying the Analgesic Palette for Pain Management

    William Peppard, PharmD, BCPS, FCCM (he/him/his) – Froedtert and the Medical College of Wisconsin Froedtert Hospital